272 related articles for article (PubMed ID: 25670647)
1. Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies.
Wang H; Gu Q; Wei J; Cao Z; Liu Q
Clin Pharmacol Ther; 2015 May; 97(5):451-4. PubMed ID: 25670647
[TBL] [Abstract][Full Text] [Related]
2. Use of Computational Functional Genomics in Drug Discovery and Repurposing for Analgesic Indications.
Lötsch J; Kringel D
Clin Pharmacol Ther; 2018 Jun; 103(6):975-978. PubMed ID: 29350398
[TBL] [Abstract][Full Text] [Related]
3. Exploring the associations between drug side-effects and therapeutic indications.
Wang F; Zhang P; Cao N; Hu J; Sorrentino R
J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
[TBL] [Abstract][Full Text] [Related]
4. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
Jang D; Lee S; Lee J; Kim K; Lee D
J Biomed Inform; 2016 Feb; 59():248-57. PubMed ID: 26707452
[TBL] [Abstract][Full Text] [Related]
5. PISTON: Predicting drug indications and side effects using topic modeling and natural language processing.
Jang G; Lee T; Hwang S; Park C; Ahn J; Seo S; Hwang Y; Yoon Y
J Biomed Inform; 2018 Nov; 87():96-107. PubMed ID: 30268842
[TBL] [Abstract][Full Text] [Related]
6. Applications of Connectivity Map in drug discovery and development.
Qu XA; Rajpal DK
Drug Discov Today; 2012 Dec; 17(23-24):1289-98. PubMed ID: 22889966
[TBL] [Abstract][Full Text] [Related]
7. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
[TBL] [Abstract][Full Text] [Related]
8. Drug Repositioning by Mining Adverse Event Data in ClinicalTrials.gov.
Su EW
Methods Mol Biol; 2019; 1903():61-72. PubMed ID: 30547436
[TBL] [Abstract][Full Text] [Related]
9. Prediction of drug gene associations via ontological profile similarity with application to drug repositioning.
Kissa M; Tsatsaronis G; Schroeder M
Methods; 2015 Mar; 74():71-82. PubMed ID: 25498216
[TBL] [Abstract][Full Text] [Related]
10. An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations.
Mullen J; Cockell SJ; Woollard P; Wipat A
PLoS One; 2016; 11(5):e0155811. PubMed ID: 27196054
[TBL] [Abstract][Full Text] [Related]
11. Use of genome-wide association studies for cancer research and drug repositioning.
Zhang J; Jiang K; Lv L; Wang H; Shen Z; Gao Z; Wang B; Yang Y; Ye Y; Wang S
PLoS One; 2015; 10(3):e0116477. PubMed ID: 25803826
[TBL] [Abstract][Full Text] [Related]
12. Computational functional genomics-based approaches in analgesic drug discovery and repurposing.
Lippmann C; Kringel D; Ultsch A; Lötsch J
Pharmacogenomics; 2018 Jun; 19(9):783-797. PubMed ID: 29792109
[TBL] [Abstract][Full Text] [Related]
13. Can medical genetics and evolutionary biology inspire drug target identification?
Wang ZY; Fu LY; Zhang HY
Trends Mol Med; 2012 Feb; 18(2):69-71. PubMed ID: 22172275
[TBL] [Abstract][Full Text] [Related]
14. Druggability of Coronary Artery Disease Risk Loci.
Tragante V; Hemerich D; Alshabeeb M; Brænne I; Lempiäinen H; Patel RS; den Ruijter HM; Barnes MR; Moore JH; Schunkert H; Erdmann J; Asselbergs FW
Circ Genom Precis Med; 2018 Aug; 11(8):e001977. PubMed ID: 30354342
[TBL] [Abstract][Full Text] [Related]
15. Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data.
Iwata H; Sawada R; Mizutani S; Yamanishi Y
J Chem Inf Model; 2015 Feb; 55(2):446-59. PubMed ID: 25602292
[TBL] [Abstract][Full Text] [Related]
16. Literature-based prediction of novel drug indications considering relationships between entities.
Jang G; Lee T; Lee BM; Yoon Y
Mol Biosyst; 2017 Jun; 13(7):1399-1405. PubMed ID: 28581007
[TBL] [Abstract][Full Text] [Related]
17. Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.
Yang CC; Zhao M
Artif Intell Med; 2019 May; 96():80-92. PubMed ID: 31164213
[TBL] [Abstract][Full Text] [Related]
18. Target-Based Drug Repositioning Using Large-Scale Chemical-Protein Interactome Data.
Sawada R; Iwata H; Mizutani S; Yamanishi Y
J Chem Inf Model; 2015 Dec; 55(12):2717-30. PubMed ID: 26580494
[TBL] [Abstract][Full Text] [Related]
19. Drug repositioning for diabetes based on 'omics' data mining.
Zhang M; Luo H; Xi Z; Rogaeva E
PLoS One; 2015; 10(5):e0126082. PubMed ID: 25946000
[TBL] [Abstract][Full Text] [Related]
20. Computational drug repositioning: from data to therapeutics.
Hurle MR; Yang L; Xie Q; Rajpal DK; Sanseau P; Agarwal P
Clin Pharmacol Ther; 2013 Apr; 93(4):335-41. PubMed ID: 23443757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
